Literature DB >> 18611855

Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy.

Mattias Häger1, Maria Giulia Bigotti, Renata Meszaros, Virginie Carmignac, Johan Holmberg, Valérie Allamand, Mikael Akerlund, Sebastian Kalamajski, Andrea Brancaccio, Ulrike Mayer, Madeleine Durbeej.   

Abstract

Mutations in the gene encoding laminin alpha2 chain cause congenital muscular dystrophy type 1A. In skeletal muscle, laminin alpha2 chain binds at least two receptor complexes: the dystrophin-glycoprotein complex and integrin alpha7beta1. To gain insight into the molecular mechanisms underlying this disorder, we performed gene expression profiling of laminin alpha2 chain-deficient mouse limb muscle. One of the down-regulated genes encodes a protein called Cib2 (calcium- and integrin-binding protein 2) whose expression and function is unknown. However, the closely related Cib1 has been reported to bind integrin alphaIIb and may be involved in outside-in-signaling in platelets. Since Cib2 might be a novel integrin alpha7beta1-binding protein in muscle, we have studied Cib2 expression in the developing and adult mouse. Cib2 mRNA is mainly expressed in the developing central nervous system and in developing and adult skeletal muscle. In skeletal muscle, Cib2 colocalizes with the integrin alpha7B subunit at the sarcolemma and at the neuromuscular and myotendinous junctions. Finally, we demonstrate that Cib2 is a calcium-binding protein that interacts with integrin alpha7Bbeta1D. Thus, our data suggest a role for Cib2 as a cytoplasmic effector of integrin alpha7Bbeta1D signaling in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18611855      PMCID: PMC3259829          DOI: 10.1074/jbc.M801166200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Molecular basis of CIB binding to the integrin alpha IIb cytoplasmic domain.

Authors:  William T Barry; Christel Boudignon-Proudhon; David D Shock; Andrew McFadden; Jonathan M Weiss; John Sondek; Leslie V Parise
Journal:  J Biol Chem       Date:  2002-05-21       Impact factor: 5.157

Review 2.  Integrins: redundant or important players in skeletal muscle?

Authors:  Ulrike Mayer
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

3.  Calcium-and integrin-binding protein regulates focal adhesion kinase activity during platelet spreading on immobilized fibrinogen.

Authors:  Meghna U Naik; Ulhas P Naik
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

4.  Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.

Authors:  L T Guo; X U Zhang; W Kuang; H Xu; L A Liu; J-T Vilquin; Y Miyagoe-Suzuki; S Takeda; M A Ruegg; U M Wewer; E Engvall
Journal:  Neuromuscul Disord       Date:  2003-03       Impact factor: 4.296

5.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

6.  Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice.

Authors:  Karl Rouger; Martine Le Cunff; Marja Steenman; Marie-Claude Potier; Nathalie Gibelin; Claude A Dechesne; Jean J Leger
Journal:  Am J Physiol Cell Physiol       Date:  2002-09       Impact factor: 4.249

Review 7.  Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models.

Authors:  Madeleine Durbeej; Kevin P Campbell
Journal:  Curr Opin Genet Dev       Date:  2002-06       Impact factor: 5.578

8.  Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice.

Authors:  Kinga Gawlik; Yuko Miyagoe-Suzuki; Peter Ekblom; Shin'ichi Takeda; Madeleine Durbeej
Journal:  Hum Mol Genet       Date:  2004-06-22       Impact factor: 6.150

9.  Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology.

Authors:  Y W Chen; P Zhao; R Borup; E P Hoffman
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

10.  CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activation.

Authors:  Weiping Yuan; Tina M Leisner; Andrew W McFadden; Zhengyan Wang; Mark K Larson; Shantres Clark; Christel Boudignon-Proudhon; Stephen C-T Lam; Leslie V Parise
Journal:  J Cell Biol       Date:  2006-01-16       Impact factor: 10.539

View more
  23 in total

1.  Identification of novel integrin binding partners for calcium and integrin binding protein 1 (CIB1): structural and thermodynamic basis of CIB1 promiscuity.

Authors:  Thomas C Freeman; Justin L Black; Holly G Bray; Onur Dagliyan; Yi I Wu; Ashutosh Tripathy; Nikolay V Dokholyan; Tina M Leisner; Leslie V Parise
Journal:  Biochemistry       Date:  2013-09-25       Impact factor: 3.162

2.  Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.

Authors:  Bruno Menezes de Oliveira; Cintia Y Matsumura; Cibely C Fontes-Oliveira; Kinga I Gawlik; Helena Acosta; Patrik Wernhoff; Madeleine Durbeej
Journal:  Mol Cell Proteomics       Date:  2014-07-03       Impact factor: 5.911

Review 3.  Atypical and ultra-rare Usher syndrome: a review.

Authors:  Rosalie M Nolen; Robert B Hufnagel; Thomas B Friedman; Amy E Turriff; Carmen C Brewer; Christopher K Zalewski; Kelly A King; Talah T Wafa; Andrew J Griffith; Brian P Brooks; Wadih M Zein
Journal:  Ophthalmic Genet       Date:  2020-05-06       Impact factor: 1.803

4.  Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands.

Authors:  Hubert J M Smeets; Bram Verbrugge; Pierre Springuel; Nicol C Voermans
Journal:  Neuromuscul Disord       Date:  2021-05-01       Impact factor: 4.296

5.  Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48.

Authors:  Saima Riazuddin; Inna A Belyantseva; Arnaud P J Giese; Kwanghyuk Lee; Artur A Indzhykulian; Sri Pratima Nandamuri; Rizwan Yousaf; Ghanshyam P Sinha; Sue Lee; David Terrell; Rashmi S Hegde; Rana A Ali; Saima Anwar; Paula B Andrade-Elizondo; Asli Sirmaci; Leslie V Parise; Sulman Basit; Abdul Wali; Muhammad Ayub; Muhammad Ansar; Wasim Ahmad; Shaheen N Khan; Javed Akram; Mustafa Tekin; Sheikh Riazuddin; Tiffany Cook; Elke K Buschbeck; Gregory I Frolenkov; Suzanne M Leal; Thomas B Friedman; Zubair M Ahmed
Journal:  Nat Genet       Date:  2012-09-30       Impact factor: 38.330

6.  Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.

Authors:  Kinga I Gawlik; Madeleine Durbeej
Journal:  Skelet Muscle       Date:  2011-03-01       Impact factor: 4.912

7.  A Novel C-Terminal CIB2 (Calcium and Integrin Binding Protein 2) Mutation Associated with Non-Syndromic Hearing Loss in a Hispanic Family.

Authors:  Kunjan Patel; Arnaud P Giese; J M Grossheim; Rashmi S Hegde; Rashima S Hegde; Maria Delio; Joy Samanich; Saima Riazuddin; Gregory I Frolenkov; Jinlu Cai; Zubair M Ahmed; Bernice E Morrow
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

8.  CIB1 and CIB2 are HIV-1 helper factors involved in viral entry.

Authors:  Ana Godinho-Santos; Allan J Hance; João Gonçalves; Fabrizio Mammano
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

9.  CIB1 is a regulator of pathological cardiac hypertrophy.

Authors:  Joerg Heineke; Mannix Auger-Messier; Robert N Correll; Jian Xu; Matthew J Benard; Weiping Yuan; Helmut Drexler; Leslie V Parise; Jeffery D Molkentin
Journal:  Nat Med       Date:  2010-07-18       Impact factor: 53.440

10.  CIB1 synergizes with EphrinA2 to regulate Kaposi's sarcoma-associated herpesvirus macropinocytic entry in human microvascular dermal endothelial cells.

Authors:  Chirosree Bandyopadhyay; Mohanan Valiya-Veettil; Dipanjan Dutta; Sayan Chakraborty; Bala Chandran
Journal:  PLoS Pathog       Date:  2014-02-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.